CV Rizos, M Elisaf, DP Mikhailidis, EN … - Expert Opin. Drug Saf., 2009 - informahealthcare.com Background: Thiazolidinediones (TZDs) are widely used antidiabetic drugs with
proven efficacy regarding mainly surrogate markers of diabetes management.
However, efficacy on surrogate markers may not always translate into ... Cited by 5 - Related articles - All 5 versions
Z Bloomgarden, Y Handelsman - Journal of Diabetes, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Related articles
GF Davies, AR Ross, TG Arnason, BHJ … - Cancer Letters, 2009 - Elsevier We previously demonstrated that the PPARγ agonist Troglitazone (TRG), a potent
antiproliferative agent, in combination with the anthracycline antibiotic
Doxorubicin (DOX), is an effective killer of multiple drug resistant (MDR) ... Related articles - All 2 versions
M Monami, C Lamanna, D Balzi, N Marchionni … - Acta Diabetologica - Springer Abstract This study was aimed at the assessment of incidence of malignancies in
type 2 diabetic patients trea- ted with different sulphonylureas. A matched
case–control study was performed. Cases were 195 diabetic patients aged ... Related articles - All 2 versions
C Jennifer… - PPAR research, 2009 - hindawi.com Breast cancer is the most prominent cancer among females in the United States.
There are a number of risk factors associated with development of breast cancer,
including consumption of a high-fat diet and obesity. Plasminogen activator ... Related articles - Cached - All 15 versions